<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00211705</url>
  </required_header>
  <id_info>
    <org_study_id>MEGA</org_study_id>
    <nct_id>NCT00211705</nct_id>
  </id_info>
  <brief_title>Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)</brief_title>
  <official_title>Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mitsukoshi Health and Welfare Foundation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Daiichi Sankyo Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Labour and Welfare, Japan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mitsukoshi Health and Welfare Foundation</source>
  <brief_summary>
    <textblock>
      To evaluate the primary preventive effect of low-dose pravastatin against coronary heart
      disease (CHD) in Japanese hypercholesterolemic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MEGA Study is the first prospective, randomized, controlled trial conducted in Japan to
      evaluate the primary preventive effect of pravastatin against CHD in daily clinical practice.
      Because the dose of pravastatin used in the MEGA Study was 10–20 mg/day, which is consistent
      with the approved doses in Japan and lower than the doses used in previous large-scale
      clinical trials.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 1994</start_date>
  <completion_date>March 2004</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Coronary Heart Disease(CHD)[fatal/non-fatal MI, sudden/cardiac death, angina, revascularization]</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke, cerebrovascular infarction(CI), CHD+CI, all cardiovascular events, total mortality</measure>
  </secondary_outcome>
  <enrollment>8000</enrollment>
  <condition>Hyperlipidemia</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diet+pravastatin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  TC:220～270mg/dl

          -  Male: 40-70 years old/ female: postmenopausal-70 years old

          -  &lt;40kg in weight

        Exclusion Criteria:

          -  FH

          -  History of CHD(angina, MI, post-PTCA/CABG, etc.)

          -  History of CVA(stroke, TIA, etc.)

          -  Underlying malignant tumor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Haruo Nakamura, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mitsukoshi Health and Welfare</affiliation>
  </overall_official>
  <reference>
    <citation>Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study Group. Design and baseline characteristics of a study of primary prevention of coronary events with pravastatin among Japanese with mildly elevated cholesterol levels. Circ J. 2004 Sep;68(9):860-7.</citation>
    <PMID>15329509</PMID>
  </reference>
  <results_reference>
    <citation>Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, Nakaya N, Nishimoto S, Muranaka M, Yamamoto A, Mizuno K, Ohashi Y; MEGA Study Group. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet. 2006 Sep 30;368(9542):1155-63.</citation>
    <PMID>17011942</PMID>
  </results_reference>
  <verification_date>June 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>November 30, 2006</last_update_submitted>
  <last_update_submitted_qc>November 30, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2006</last_update_posted>
  <keyword>Hyperlipidemia</keyword>
  <keyword>coronary heart disease</keyword>
  <keyword>prevention</keyword>
  <keyword>stroke</keyword>
  <keyword>pravastatin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pravastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

